Nordic Nanovector: Invitation to webcast regarding proposed merger with APIM Therapeutics

OSLO, Norway, Nov. 23, 2022 /PRNewswire/ -- Nordic Nanovector ASA (OSE: NANOV) ("Nordic Nanovector" or the "Company") will host a webcast, including a question and answers session on Thursday, November 24 at 4.30 P.M. CET. Reference is made to the stock exchange announcement regarding the Company comments on the proposed merger with APIM Therapeutics November 21. A webcast will be held as described below:

Participation details

In order to listen to the presentation, visit the Company's website www.nordicnanovector.com and click on the link to "Webcast", or sign up and access directly via the webcast link below:

https://events.webcast.no/viewer-registration/MHAsFYHC/register

We encourage viewers to register for the webcast 5-10 minutes prior to the presentation.

The presentation will be held in English. A Q&A session in both English and Norwegian will be held after the presentation. Information on how to submit questions will be given at the beginning of the session. Any questions may be submitted to ir@nordicnanovector.com in advance. 

The presentation material will be made available on www.nordicnanovector.com and a replay of the webcast will also be made available at this website.

Participants from The Company and APIM Therapeutics

Jan H. Egberts

Chairman of the Board

Nordic Nanovector

Malene Brondberg

Interim CEO and CFO

Nordic Nanovector

Kostas Alevizopoulos

CEO

APIM Therapeutics

Important information

This announcement is not and does not form a part of any offer to sell, or a solicitation of an offer to purchase, any securities. The distribution of this announcement and other information may be restricted by law in certain jurisdictions. Copies of this announcement are not being made and may not be distributed or sent into any jurisdiction in which such distribution would be unlawful or would require registration or other measures. Persons into whose possession this announcement or such other information should come are required to inform themselves about and to observe any such restrictions.

Matters discussed in this announcement constitute forward-looking statements. Forward-looking statements are statements that are not historical facts and may be identified by words such as "believe", "expect", "anticipate", "strategy", "intends", "estimate", "will", "may", "continue", "should" and similar expressions. The forward-looking statements in this release are based upon various assumptions, many of which are based, in turn, upon further assumptions. Although Nordic Nanovector believes that these assumptions were reasonable when made, these assumptions are inherently subject to significant known and unknown risks, uncertainties, contingencies, and other important factors which are difficult or impossible to predict and are beyond its control.

The information, opinions and forward-looking statements contained in this announcement speak only as at its date and are subject to change without notice. Nordic Nanovector undertakes no obligation to review, update, confirm, or to release publicly any revisions to any forward-looking statements to reflect events that occur or circumstances that arise in relation to the content of this announcement.

This announcement is for information purposes only and is not to be relied upon in substitution for the exercise of independent judgment. It is not intended as investment advice and under no circumstances is it to be used or considered as an offer to sell, or a solicitation of an offer to buy any securities or a recommendation to buy or sell any securities.